Skip to main content
. Author manuscript; available in PMC: 2013 Jan 17.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1443–1450. doi: 10.1158/1055-9965.EPI-06-0144

Table 3.

Number and type of Ki-ras mutation, effected codon, and amino acid change

Codon Type of mutation* No. of mutations (%) Wild-type codon (amino acids) Mutated codon (amino acids) Altered amino acids
12 (n = 112) G-to-T 57 (41.3%) GGT (Gly) GTT (Val) 45 (32.6)
TGT (Cys) 12 (8.7)
G-to-A 44 (31.9) GAT (Asp) 32 (23.2)
AGT (Ser) 12 (8.7)
G-to-C 10 (7.2) GCT (Ala) 8 (5.8)
CGT (Arg) 2 (1.4)
T-to-C 1 (0.7) GGC (Gly) No change
13 (n = 26) G-to-T 2 (1.4) GGC (Gly) TGC (Arg) 2 (1.4)
G-to-A 23 (16.7) GAC (Asp) 22 (15.9)
GAC (Asp) 1 (0.7)
G-to-C 1 (0.7) AGC (Ser) 1 (0.7)
*

For seven subjects, two mutations were found and are included.

Amino acids abbreviated as follows: glycine (Gly), valine (Val), cysteine (cys), aspartic acid (Asp), alanine (Ala), arginine (Arg), and serine (Ser).